Marschall Runge
Cardiovascular Disease · Ann Arbor, MINPI 1841351970
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,716,083 of the $1,756,838 with a category attached, or 97.7%. Every reported general payment came from a single manufacturer, Eli Lilly. Among cardiovascular disease clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $6121.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1.8M
What the payments were for
- Speaking & faculty fees$1,716,08398%
- Travel & lodging$34,2742%
- Food & beverage$6,4810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 287 | $1,756,838 |
How this compares
$1,756,838 in reported general payments places this provider in the 95th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Ann Arbor
- Vallerie McLaughlinAnn Arbor$947K
- Stanley ChetcutiAnn Arbor$573K
- David BachAnn Arbor$390K
- Bertram PittAnn Arbor$298K
- Victor MolesAnn Arbor$120K
- Salim HayekAnn Arbor$92K
- Ashwini KerkarAnn Arbor$84K
- Priya MehtaAnn Arbor$70K
- Raymond YeowAnn Arbor$61K
- Eric GoodAnn Arbor$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.